Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer
Srpcic Matevz, Jordan Taja, Popuri Karteek and 1 more
Radiology and Oncology · 2020
doi:10.2478/raon-2020-0016 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Esophageal cancer remains a disease with poor survival and many complications. Measuring muscle mass and quality can identify patients with diminished muscle mass (sarcopenia) and muscle fat infiltration (myosteatosis). We studied the impact of sarcopenia and myosteatosis in resectable esophageal cancer on overall survival and complications.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.